Skip to content

Allergy Is Not Just One Disease, It’s a Whole Body System

By Doanh Nguyen, MD FAAAAI, 04/22/2026

Allergy Is Not Just One Disease, It’s a Whole Body System

For much of modern medicine, allergies have been treated as separate conditions, eczema of the skin, asthma of the lungs, food allergy of the gut. Yet a growing body of research suggests these disorders are not isolated at all. Instead, they represent different expressions of a single, interconnected process unfolding across the body’s barrier surfaces. 


This shift in perspective reframes allergy as a systems level condition, shaped by the interaction between the environment, the immune system, and the body’s protective linings. What appears on the surface as a rash, a wheeze, or a food reaction may, in fact, be part of a broader biological conversation happening across multiple organs.


The Atopic March: A Pattern Hiding in Plain Sight


Clinicians have long observed that allergic diseases often follow a predictable sequence. A child who develops eczema early in life may later go on to experience food allergies, then hay fever, and eventually asthma. This progression, known as the “atopic march,” has traditionally been described as a series of separate diagnoses appearing over time.


But a systems view suggests something deeper. Rather than independent events, these conditions may reflect the gradual evolution of a single underlying process. Early disruptions in the body’s protective barriers can set the stage for immune sensitization, which then unfolds across different tissues as the individual grows. In this light, the atopic march is not simply a timeline, it is a map of how disease spreads through a connected biological network.


The Body’s Barriers: More Than Just a Wall


At the center of this network lies the epithelial barrier, the thin layer of cells that lines the skin, lungs, and digestive tract. These surfaces serve as the body’s first line of defense, shielding internal systems from the outside world while selectively allowing beneficial interactions.


Far from being passive, these barriers are biologically active. They sense environmental exposures, communicate with immune cells, and help maintain balance between tolerance and defense. When functioning properly, they allow the body to coexist peacefully with a constant stream of external stimuli. But when these barriers weaken, that balance begins to shift.


When Protection Fails


Barrier dysfunction can arise from a combination of genetic vulnerability, environmental exposure, and biochemical changes within the tissue itself. Structural proteins may be reduced, lipids that maintain hydration and integrity may be depleted, and the microscopic junctions that hold cells together may loosen.


As a result, substances that would normally be excluded, pollens, food proteins, microbes, and pollutants, can penetrate more deeply into the tissue. The immune system, encountering these materials in the wrong context, may interpret them as threats.


This process marks the beginning of allergic sensitization. What starts as a local breach can quickly escalate into a systemic response, as immune signals spread beyond the initial site of injury.


A Conversation Between Organs


One of the most striking insights from recent research is that the skin, gut, and lungs do not operate independently. Instead, they communicate through a shared network of immune signals.


When the barrier in one organ is disrupted, it can release molecular “alarms” that travel through the bloodstream. These signals can influence distant tissues, altering their own barrier function and immune responses. In this way, a problem that begins in the skin can affect the lungs, or a disturbance in the gut can shape immune activity elsewhere.


This interconnection helps explain why allergic diseases often cluster together. The body is not experiencing multiple unrelated problems, it is responding as an integrated system.


The Microbial Dimension


Adding another layer of complexity is the microbiome, the vast community of microorganisms that live on and within the body. These microbes play a critical role in maintaining barrier integrity and guiding immune development. In a healthy state, the microbiome helps reinforce the body’s defenses and promotes tolerance to harmless substances. But when this microbial balance is disrupted, a condition known as dysbiosis, the protective effects can diminish.


Certain microbes may overgrow, releasing substances that further damage the barrier or amplify inflammation. At the same time, beneficial organisms that produce anti-inflammatory signals may decline. The result is a system that becomes more reactive, less stable, and increasingly prone to allergic responses.


Environment and the Modern Allergy Epidemic


The rise in allergic diseases over recent decades has drawn attention to the role of the modern environment. Air pollution, chemical exposures, and changes in lifestyle have introduced new pressures on the body’s barrier systems. Even everyday substances, such as detergents and cleaning agents, can disrupt the delicate structures that maintain barrier integrity. Meanwhile, reduced exposure to diverse natural environments may limit the immune system’s ability to learn tolerance during early life.


These environmental influences do not act in isolation. They interact with genetic predispositions and microbial changes, creating a cumulative burden that can push the system toward chronic inflammation.


How Exposure Shapes the Immune System


One of the most intriguing discoveries in allergy research is that the route by which the body encounters a substance can determine whether it becomes tolerant or allergic to it. Exposure through a compromised skin barrier tends to promote sensitization, priming the immune system to react. In contrast, exposure through the digestive tract, particularly early in life, can promote tolerance, teaching the immune system to accept the substance as harmless.


This insight has reshaped thinking around prevention, suggesting that timing and context of exposure may be as important as the exposure itself.


Toward a New Model of Treatment


As the understanding of allergy shifts from isolated organs to interconnected systems, approaches to treatment are evolving as well. Rather than focusing solely on suppressing symptoms, new strategies aim to address the underlying drivers of disease.


Efforts to restore barrier function, support microbial balance, and modulate specific immune pathways are becoming central to care. These approaches reflect a broader goal: not just to control allergic reactions, but to stabilize the system that gives rise to them.


A Broader View of Health


The emerging science of allergy suggests that what we experience as disease is often the visible outcome of deeper, system-wide changes. Barrier dysfunction, immune signaling, and environmental exposure come together to shape how the body responds to the world around it.


Seen through this lens, allergy is not simply an overreaction. It is a reflection of how the body’s most exposed surfaces, its interfaces with the environment, adapt, communicate, and sometimes fail.


Understanding these connections offers more than a new explanation. It opens the possibility of earlier intervention, more precise treatment, and perhaps, in time, the prevention of allergic disease altogether.


Reference

1. Krempski JW, Dant C, Nadeau KC. The origins of allergy from a systems approach. Ann Allergy Asthma Immunol. 2020;125(5):507-516. doi:10.1016/j.anai.2020.07.013

2. Zhu TH, Zhu TR, Tran KA, Sivamani RK, Shi VY. Epithelial barrier dysfunctions in atopic dermatitis: a skin-gut-lung model linking microbiome alteration and immune dysregulation. Br J Dermatol. 2018;179(3):570-581. doi:10.1111/bjd.16734

3. Holgate ST. The airway epithelium is central to the pathogenesis of asthma. Allergol Int. 2008;57(1):1-10. doi:10.2332/allergolint.R-07-154

4. Akdis CA, Arkwright PD, Brüggen MC, et al. Type 2 immunity in the skin and lungs. Allergy. 2020;75(7):1582-1605. doi:10.1111/all.14318

5. Goleva E, Berdyshev E, Leung DY. Epithelial barrier repair and prevention of allergy. J Clin Invest. 2019;129(4):1463-1474. doi:10.1172/JCI124608